Polymorphisms of T- cell leukemia 1A gene loci are not related to the development of adjuvant letrozole-induced adverse events in breast cancer

Letrozole, an aromatase inhibitor (AI), is the first-line adjuvant drug for treating hormone receptor-positive (HR+) breast cancer in postmenopausal women. However, harmful adverse events (AEs) and significant differences in drug response among individuals remain a significant problem in clinical ap...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PLoS One
Hauptverfasser: Umamaheswaran, Gurusamy, Kadambari, Dharanipragada, Muthuvel, Suresh Kumar, Kumar, Naveena A. N., Dubashi, Biswajit, Aibor Dkhar, Steven, Adithan, Chandrasekaran
Format: Artigo
Sprache:Inglês
Veröffentlicht: Public Library of Science 2021
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7990231/
https://ncbi.nlm.nih.gov/pubmed/33760860
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0247989
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge